Evidence map›Paper›PMID 37321613›Full record

ArticleThe European respiratory journal2023

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee.

Alvar Agustí, Antonio Anzueto, Bartolome R Celli, Kevin Mortimer, Sundeep Salvi, Claus F Vogelmeier, GOLD Scientific Committee

Abstract readLetterComment
In one paragraph

Article in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?International journal of chronic obstructive pulmonary disease · 2023
    Trial
  2. Pre-COPD, PRISm, and COPD in young adults born preterm.Annals of the American Thoracic Society · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Normal Blood Eosinophil Counts in Humans.Respiration; international review of thoracic diseases · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alvar AgustíUniv. Barcelona, Hospital Clinic, IDIBAPS and CIBERES, Barcelona, Spain aagusti@clinic.cat.
Antonio AnzuetoSouth Texas Veterans Health Care System, University of Texas, San Antonio, TX, USA.
Bartolome R CelliBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7266-8371
Kevin MortimerLiverpool University Hospitals NHS Foundation Trust, Liverpool, UK.ORCID 0000-0002-8118-8871
Sundeep SalviPulmocare Research and Education (PURE) Foundation, Pune, India.
Claus F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, German Center for Lung Research (DZL), Marburg, Germany.
GOLD Scientific Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary Disease, Chronic ObstructiveHumans

Identifiers

PMID37321613
PMCPMC10269375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.